ArGEN-X BV has recruited a new venture capital investor to its cohort of financial supporters enabling it to prepare to move a novel antibody fragment with potential for autoimmune diseases into the clinic. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
